The Crtc1-Nedd9 Signaling Axis Mediates Lung Cancer Progression Caused By Lkb1 Loss

Yan Feng,Ye Wang,Zuoyun Wang,Zhaoyuan Fang,Fei Li,Yijun Gao,Hongyan Liu,Tian Xiao,Fuming Li,Yang Zhou,Qiwei Zhai,Xiaolong Liu,Yihua Sun,Nabeel Bardeesy,Kwok-kin Wong,Haiquan Chen,Zhi-qi Xiong,Hongbin Ji

DOI: https://doi.org/10.1158/0008-5472.CAN-12-1909

IF: 11.2

2012-01-01

Cancer Research

Abstract:Somatic mutation of the tumor suppressor gene LKB1 occurs frequently in lung cancer where it causes tumor progression and metastasis, but the underlying mechanisms remain mainly unknown. Here, we show that the oncogene NEDD9 is an important downstream mediator of lung cancer progression evoked by LKB1 loss. In de novo mouse models, RNAi-mediated silencing of Nedd9 inhibited lung tumor progression, whereas ectopic NEDD9 expression accelerated this process. Mechanistically, LKB1 negatively regulated NEDD9 transcription by promoting cytosolic translocation of CRTC1 from the nucleus. Notably, ectopic expression of either NEDD9 or CRTC1 partially reversed the inhibitory function of LKB1 on metastasis of lung cancer cells. In clinical specimens, elevated expression of NEDD9 was associated with malignant progression and metastasis. Collectively, our results decipher the mechanism through which LKB1 deficiency promotes lung cancer progression and metastasis, and provide a mechanistic rationale for therapeutic attack of these processes. Cancer Res; 72(24); 6502-11. (c) 2012 AACR.